What is it about?
This study examines oxidative stress in untreated multiple myeloma (MM) and monoclonal gammopathy of uncertain significance (MGUS). It measures circulating protein oxidation markers—AOPPs, AGEs, and S‑nitrosylated proteins—in patients and controls. The analysis also compares MM patients with and without lytic bone lesions.
Featured Image
Photo by National Institute of Allergy and Infectious Diseases on Unsplash
Why is it important?
The findings show higher oxidative stress in MM than in MGUS and controls, and even higher levels in MM patients with bone lesions. This supports a close association between oxidative stress and disease burden in MM. Understanding this relationship may help clarify mechanisms involved in disease progression and complications.
Perspectives
The study is observational and focused on serum biomarkers, so causality cannot be established. Oxidative stress likely reflects complex interactions rather than a single driver of disease. Further research is needed to explore mechanisms and to assess whether these markers have prognostic or monitoring value.
Prof. Antonio Speciale
University of Messina
Read the Original
This page is a summary of: Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions, Inflammation Research, June 2012, Springer Science + Business Media,
DOI: 10.1007/s00011-012-0498-7.
You can read the full text:
Contributors
The following have contributed to this page
